Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Agreen, Hadadi"'
Autor:
Tony Zibo Zhuang, Lara Harik, Seth Force, Agreen Hadadi, Mehmet Asim Bilen, Jacqueline T. Brown, Bradley C. Carthon, Jamie Goldman, Omer Kucuk, Viraj A. Master, Bassel Nazha
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma is a subject of debate. We report a durable complete response in a 62-year-old man Jehovah’s Witness with metastatic clear cell renal cell carcinoma who received
Externí odkaz:
https://doaj.org/article/82d35e8cfd2f4bd2a107b982a151d13f
Autor:
Agreen Hadadi, Harris Krause, Andrew Elliott, Alex Patrick Farrell, Jacqueline T Brown, Bassel Nazha, Lara Harik, Bradley Curtis Carthon, Chadi Nabhan, Pedro C. Barata, Mohamed Saleh, Yuanquan Yang, W. Michael Korn, Rana R. McKay, Mehmet Asim Bilen
Publikováno v:
Journal of Clinical Oncology. 41:555-555
555 Background: Human epidermal growth factor receptor 2 (HER2) expression has been associated with poor prognosis in urothelial carcinoma (UC). Recent data suggests that HER2-targeted antibody-drug conjugate (ADC) treatment is efficacious. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3f22ccd01060210e635465ae971018
https://doi.org/10.1200/jco.2023.41.6_suppl.555
https://doi.org/10.1200/jco.2023.41.6_suppl.555
Autor:
Agreen Hadadi, Katherine ER Smith, Limeng Wan, Jacqueline R Brown, Greta Russler, Lauren Yantorni, Sarah Caulfield, Jennifer Lafollette, Melvin Moore, Omer Kucuk, Bradley Carthon, Bassel Nazha, Yuan Liu, Mehmet A Bilen
Publikováno v:
Urol Oncol
BACKGROUND: Biomarkers have the potential to provide clinical guidance, but there is limited data for biomarkers in metastatic hormone sensitive prostate cancer (mHSPC). METHODS: We performed a retrospective multicenter review from Winship Cancer Ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a8e92fc050c286e0d9d193f68180eb
https://doi.org/10.1016/j.urolonc.2022.03.016
https://doi.org/10.1016/j.urolonc.2022.03.016
Autor:
Grant Rauterkus, Agreen Hadadi, Reagan Barnett, Caroline Weipert, Leylah Drusbosky, Xin Gao, Michael B. Lilly, Alan Haruo Bryce, Syed Arsalan Ahmed Naqvi, Pedro C. Barata, Mehmet Asim Bilen
Publikováno v:
Journal of Clinical Oncology. 40:165-165
165 Background: A prior study of patients with advanced cancers treated with immune checkpoint inhibitors (ICI) associated improved overall survival with tissue tumor mutational burden above the 80th percentile in each histology (tTMB-H). TMB can als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46ff0b2d9f9a0825ed5079d39ab92176
https://doi.org/10.1200/jco.2022.40.6_suppl.165
https://doi.org/10.1200/jco.2022.40.6_suppl.165
Publikováno v:
The American Surgeon. 84:259-261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::099c6162435ca93f3d882f5f68ffccdc
https://doi.org/10.1177/000313481808400719
https://doi.org/10.1177/000313481808400719
Publikováno v:
The American surgeon. 84(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21972f83fdb47dd5a996bf950fb107d6
https://pubmed.ncbi.nlm.nih.gov/30401032
https://pubmed.ncbi.nlm.nih.gov/30401032
Publikováno v:
Hormonescancer. 5(1)
17β-estradiol (E2) plays a key role in tumorigenesis by enhancing cell survivability and metastasis through its cytoplasmic receptors. Recently, a variant of estrogen receptor alpha, ERα36 has been implicated as a substantial mediator of E2’s pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2904c9401ea5a393c2720b35be253798
https://pubmed.ncbi.nlm.nih.gov/24081562
https://pubmed.ncbi.nlm.nih.gov/24081562
Autor:
Natalia Cuenca, Rene Olivares-Navarrete, Barbara D. Boyan, Zvi Schwartz, Agreen Hadadi, Reyhaan A. Chaudhri
Publikováno v:
The Journal of biological chemistry. 287(10)
Protein kinase C (PKC) signaling can be activated rapidly by 17β-estradiol (E(2)) via nontraditional signaling in ERα-positive MCF7 and ERα-negative HCC38 breast cancer cells and is associated with tumorigenicity. Additionally, E(2) has been shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5882a13fef87f5f7761f10a61577ef7
https://pubmed.ncbi.nlm.nih.gov/22247547
https://pubmed.ncbi.nlm.nih.gov/22247547
Publikováno v:
Cancer Research. 73:504-504
Steroid hormones exhibit dynamic effects on cancer progression. 17β-estradiol (E2), in particular, enhances tumor growth and development through a non-classical estrogen receptor (ER) found in the plasma membrane of triple negative breast cancer (TN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d78dc3e740775759c26e7e76f2cc2634
https://doi.org/10.1158/1538-7445.am2013-504
https://doi.org/10.1158/1538-7445.am2013-504